Paradromics
Neurotechnology · United States · Founded 2015 · private
Paradromics implanted its 421-electrode Connexus device in its first trial participant in June 2026, eleven years after it was founded and a year after an acute, minutes-long test that had already been reported as first-in-human.
The record
2 figures · 1 rounds · 3 backers · 4 feed items
Every one of them carries its source, its date, and its age when it has one. Reading the record takes a free account; the account is how you keep a watchlist.